Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Tzeng, Horng Tay ^a   Tsai, Hwei Fang ^b,c   Chyuan, I Tsu ^d   Liao, Hsiu Jung ^a   Chen, Chun Jen ^e   Chen, Pei Jer ^a   Hsu, Ping Ning ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ASC PROTEIN; BETA INTERFERON RECEPTOR; CRYOPYRIN; ETANERCEPT; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 1 RECEPTOR; MDA5 PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROGRAMMED DEATH 1 RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS B VIRUS; IMMUNE RESPONSE; INNATE IMMUNITY; INTRA HEPATIC LEUKOCYTE; KNOCKOUT MOUSE; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VIRAL CLEARANCE; VIRUS CORE; VIRUS GENE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LIVER; METABOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; IMMUNITY, INNATE; LIVER; MICE; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 84904681494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103008     Document Type: Article

References (38)

1. Pungpapong S, Kim WR, Poterucha JJ (2007) Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 82: 967-975. (Pubitemid 47206372)
2. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, et al. (1996) Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98: 1185-1194. (Pubitemid 26299932)
3. Bertoletti A, Ferrari C (2012) Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61: 1754-1764.
4. Bertoletti A, Ferrari C (2013) Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Postgrad Med J 89: 294-304.
5. Durantel D, Zoulim F (2009) Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology 50: 1692-1695.
6. Yang PL, Althage A, Chung J, Maier H, Wieland S, et al. (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 107: 798-802.
7. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, et al. (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 1371: 289-300.
8. Guo H, Jiang D, Ma D, Chang J, Dougherty AM, et al. (2009) Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol 83: 847-858.
9. Lütgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann JH, et al. (2011) Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice, Gastroenterology 140: 2074-2083.
10. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, et al. (2007) Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204: 667-680. (Pubitemid 46457088)
11. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, et al. (2009) Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160.
12. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, et al. (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 6: e1001227.
13. Hussain MJ, Lau JY, Williams R, Vergani D (1994) Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection. J Clin Pathol 47: 1112-1115.
14. Peng G, Li S, Wu W, Tan X, Chen Y, et al. (2008) PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 45: 963-970. (Pubitemid 350019503)
15. Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, et al. (2010) Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138: 682-693.
16. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, et al. (2003) Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98: 144-150. (Pubitemid 36135183)
17. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenefelde KH, et al. (1998) A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111: 579-582. (Pubitemid 28160904)
18. Perez-Alvarez R, Diaz-Lagares C, Garcia-Hernandez F, Lopez-Roses L, Brito-Zeron P, et al. (2011) Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases. Medicine (Baltimore) 90: 359-371.
19. Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, et al. (2011) Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibodypositive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy. Ann Rheum Dis 70: 1719-1725.
20. Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669-6674. (Pubitemid 38586032)
21. Huang LR, Wu HL, Chen PJ, Chen DS (2006) An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 103: 17862-17867.
22. Lin YJ, Huang LR, Yang HC, Tzeng HT, Hsu PN, et al. (2010) Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model. Proc Natl Acad Sci U S A 107: 9340-9345.
23. Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, et al. (2012) PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One 7: e39179.
24. Yang ST, Yen CJ, Lai CH, Lin YJ, Chang KC, et al. (2013) SUMOylated CPAP is required for IKK-mediated NF-kappaB activation and enhances HBx-induced NF-kappaB signaling in HCC. J Hepatol 58: 1157-1164.
25. Lin YJ, Wu HL, Chen DS, Chen PJ (2012) Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice. J Virol 86: 9266-9273.
26. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, et al. (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81: 4215-4225. (Pubitemid 46586915)
27. + T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 80: 3532-3540.
28. Hösel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782.
29. Brunda MJ, Rosenbaum D (1984) Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Cancer Res 44: 597-601. (Pubitemid 14187459)
30. Neta R, Oppenheim JJ, Douches SD (1988) Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J Immunol 140: 108-111. (Pubitemid 18050689)
31. Gilles PN, Fey G, Chisari FV (1992) Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol 66: 3955-3960.
32. Xu L, Yin W, Sun R, Wei H, Tian Z (2013) Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in HBV-persistent mice. Hepatology accepted (10.1002/hep.26668).
33. Wang H, Ryu WS (2010) Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6: e1000986.
34. Yu S, Chen J, Wu M, Chen H, Kato N, et al. (2010) Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91: 2080-2090.
35. Biermer M, Puro R, Schneider RJ (2003) Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol 77: 4033-4042. (Pubitemid 36350944)
36. Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, et al. (2013) Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol 14: 574-583.
37. Heise T, Guidotti LG, Cavanaugh VJ, Chisari FV (1999) Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol 73: 474-481. (Pubitemid 28565392)
38. Phillips S, Chokshi S, Riva A, Evans A, Williams R, et al. (2010) CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 184: 287-295.